"Day and night, St. Luke's care team is prepared for a full range of medical emergencies—from critical injuries to life-threatening illnesses. Our extended team includes first responders, paramedics, firefighters, law enforcement and emergency medical professionals. At remote locations and during transport, these individuals perform life-saving interventions with courage and dedication."

During the past decade, Saint Luke's Hospital of Duluth conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 35 clinical trials were completed, i.e. on average, 102.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 19 clinical trials were completed. i.e. 211.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Luke's Hospital of Duluth" #1 sponsor was "National Cancer Institute (NCI)" with 29 trials, followed by "NRG Oncology" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored and "Boston Scientific Corporation" with 5 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's Hospital of Duluth" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Saint Luke's Hospital of Duluth" are "Prostate Cancer" (5 trials), "Breast Cancer" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials) and "Fallopian Tube Endometrioid Adenocarcinoma" (3 trials). Many other conditions were trialed in "Saint Luke's Hospital of Duluth" in a lesser frequency.

Most popular intervention types in "Saint Luke's Hospital of Duluth" are "Drug" (56 trials), "Other" (35 trials), "Biological" (20 trials), "Radiation" (19 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (16 trials), "Paclitaxel" (8 trials), "Placebo" (8 trials) and "Bevacizumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Saint Luke's Hospital of Duluth" are 55 trials for "All" genders, 13 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Luke's Hospital of Duluth". undefined are not yet recruiting, 11 are recruiting, 33 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Saint Luke's Hospital of Duluth, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Luke's Hospital of Duluth, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

Saint Luke's Hospital of Duluth has several departments that took part in Clinical trials: "St. Luke's Hospital Cancer Care Center" - 29 trials